Braveheart Bio, Inc. · NASDAQ:BRVE
OrbiMed Genesis GP LLC bought 1,940,000 Braveheart Bio, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 11, 2026
On Aug 7, 2026, OrbiMed Genesis GP LLC (Director, 10% owner) bought 1,940,000 Braveheart Bio, Inc. shares at US$18.00 for US$34.9M, leaving 273,333 shares. Filed Aug 11, 2026 (Form 4).
- Bought
- 1,940,000 shares
- Price
- US$18.00
- Value
- US$34.9M
- Holding after
- 273,333 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Conversion | 9,132,420 | 10,235,159 | Indirect | |
| Aug 7, 2026 | Common Stock | Buy | 1,666,667 | US$18.00 | 11,901,826 | Indirect |
| Aug 7, 2026 | Common Stock | Buy | 273,333 | US$18.00 | 273,333 | Indirect |
Source
Related
- Braveheart Bio, Inc.
- OrbiMed Genesis GP LLC
- Braveheart Bio, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Sep 10, 2026
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13D · AH Bio Fund IV, L.P. · Aug 14, 2026
- Form 4 · Andreessen Marc L · Aug 11, 2026